Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8


Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.

Franzén M, Hägglund G, Alriksson-Schmidt A.

BMC Musculoskelet Disord. 2017 Dec 11;18(1):520. doi: 10.1186/s12891-017-1880-y.


Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement.

Schramm A, Bäumer T, Fietzek U, Heitmann S, Walter U, Jost WH.

J Neural Transm (Vienna). 2015 Oct;122(10):1457-63. doi: 10.1007/s00702-014-1356-2. Epub 2014 Dec 30. Review.


Comparison of treatment effects between children with spastic cerebral palsy under and over five years after botulinum toxin type a injection.

Lee WY, Park GY, Kwon DR.

Ann Rehabil Med. 2014 Apr;38(2):200-8. doi: 10.5535/arm.2014.38.2.200. Epub 2014 Apr 29.


Intrathecal baclofen pump for spasticity: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(7):1-93. Epub 2005 May 1.


Neurologic uses of botulinum neurotoxin type A.

Ney JP, Joseph KR.

Neuropsychiatr Dis Treat. 2007 Dec;3(6):785-98.


Therapeutic choices in the locomotor management of the child with cerebral palsy--more luck than judgement?

Patrick JH, Roberts AP, Cole GF.

Arch Dis Child. 2001 Oct;85(4):275-9. Review. No abstract available.

Supplemental Content

Support Center